HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yoshitaka Kikukawa Selected Research
Yoshitaka Kikukawa Research Topics
Disease
7
Multiple Myeloma
01/2019 - 10/2008
7
Neoplasms (Cancer)
11/2016 - 10/2008
3
Lymphoma (Lymphomas)
01/2022 - 01/2015
2
Amyloidosis
01/2016 - 02/2015
2
Immunoglobulin Light-chain Amyloidosis
01/2016 - 02/2015
2
Waldenstrom Macroglobulinemia (Macroglobulinemia)
02/2015 - 01/2015
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
05/2022
1
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
11/2018
1
Cytopenia
07/2018
1
Pancytopenia
07/2018
1
Nephrotic Syndrome (Syndrome, Nephrotic)
01/2016
1
Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy)
01/2016
1
Ovarian Neoplasms (Ovarian Cancer)
06/2015
1
Hypersensitivity (Allergy)
06/2015
1
Rare Diseases (Rare Disease)
02/2015
1
Monoclonal Gammopathy of Undetermined Significance
02/2015
1
Cardiac Sudden Death (Sudden Cardiac Arrest)
02/2015
1
Neoplasm Metastasis (Metastasis)
01/2015
1
Polyneuropathies (Polyneuropathy)
01/2015
1
Splenomegaly
01/2015
1
POEMS Syndrome (Syndrome, POEMS)
01/2015
1
Edema (Dropsy)
01/2015
1
Hypoxia (Hypoxemia)
12/2013
1
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2012
1
Type 2 Diabetes Mellitus (MODY)
01/2012
1
Plasmacytoma
01/2012
1
Hyperglycemia
01/2012
1
Thrombocytopenia (Thrombopenia)
10/2008
Drug/Important Bio-Agent (IBA)
3
Dexamethasone (Maxidex)
FDA Link
Generic
05/2018 - 02/2015
3
Bortezomib (Velcade)
FDA Link
05/2018 - 12/2013
3
Thalidomide (Thalomid)
FDA Link
05/2018 - 10/2010
2
Rituximab (Mabthera)
FDA Link
11/2018 - 01/2015
2
Paraffin
IBA
11/2016 - 01/2012
2
Proteins (Proteins, Gene)
FDA Link
11/2016 - 01/2015
2
Amyloid (Amyloid Fibrils)
IBA
01/2016 - 02/2015
2
Lenalidomide (CC 5013)
FDA Link
01/2016 - 02/2015
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2016 - 02/2015
2
Melphalan (Alkeran)
FDA Link
Generic
02/2015 - 10/2008
1
Interleukin-2 Receptors (IL 2 Receptor)
IBA
05/2022
1
mogamulizumab
IBA
01/2022
1
Immunoglobulin A (IgA)
IBA
01/2019
1
Factor XIII (Coagulation Factor XIII)
IBA
01/2019
1
Gallium
IBA
11/2018
1
obinutuzumab
IBA
11/2018
1
Familial apoceruloplasmin deficiency
IBA
07/2018
1
Copper
IBA
07/2018
1
Ceruloplasmin (Ferroxidase)
IBA
07/2018
1
Mucins
IBA
11/2016
1
Immune Checkpoint Proteins
IBA
11/2016
1
Immunoglobulins (Immunoglobulin)
IBA
11/2016
1
Ligands
IBA
11/2016
1
Interleukin-27 (Interleukin 27)
IBA
11/2016
1
Immunoglobulin Light Chains (Immunoglobulin Light Chain)
IBA
01/2016
1
Carboplatin (JM8)
FDA Link
Generic
06/2015
1
Platinum
IBA
06/2015
1
Proteasome Inhibitors
IBA
03/2015
1
shikonin
IBA
03/2015
1
DNA (Deoxyribonucleic Acid)
IBA
01/2015
1
Immunoglobulin M (IgM)
IBA
01/2015
1
Nucleic Acids
IBA
01/2015
1
Lactic Acid (Lactate)
FDA Link
Generic
01/2015
1
Dasatinib (BMS 354825)
FDA Link
01/2012
1
Glucose (Dextrose)
FDA Link
Generic
01/2012
1
Tyrosine Kinase Inhibitors
IBA
01/2012
1
Clarithromycin (Biaxin)
FDA Link
Generic
10/2010
1
cepharanthine
IBA
10/2008
1
Alkaloids
IBA
10/2008
Therapy/Procedure
3
Drug Therapy (Chemotherapy)
01/2022 - 10/2008
2
Therapeutics
05/2018 - 10/2008
1
Immunotherapy
11/2016
1
Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
02/2015